Table 2.

Multiple Regression Analysis of Factors Affecting Reductions in HbA1c

	Estimate (95% CI)	P value	VIF
Age	0.003 (−0.002, 0.008)	0.273	1.48
Female sex	−0.106 (−0.215, 0.003)	0.057	1.18
BMI	0.001 (−0.010, 0.012)	0.840	1.30
Heart failure	0.004 (−0.110, 0.118)	0.944	1.22
Diabetes	−0.192 (−0.307, −0.078)	0.001	1.17
Hypertension	0.005 (−0.130, 0.140)	0.068	1.13
Treatment period (weeks)	−0.005 (−0.016, 0.005)	0.280	1.08
S/V dose (per 100 mg)	0.003 (−0.002, 0.008)	0.920	1.03

BMI, body mass index; CI, confidence interval; S/V, sacubitril/valsartan; VIF, variance inflation factor.